Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 151 results:
Συντάκτης Τίτλος [ Τύπος] Έτος Φίλτρα: Συντάκτης is Mikhailidis, Dimitri P [Clear All Filters]
Smoking and non-alcoholic steatohepatitis (NASH): the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) trial..
J Hepatol. 57(2), 476.
(2012). Should we expand the concept of coronary heart disease equivalents?.
Curr Opin Cardiol. 29(4), 389-95.
(2014). Should raising high-density lipoprotein cholesterol be a matter of debate?.
J Cardiovasc Med (Hagerstown). 13(4), 254-9.
(2012). Should adipokines be considered in the choice of the treatment of obesity-related health problems?.
Curr Drug Targets. 11(1), 122-35.
(2010). Short-, mid-, and long-term benefits of peri-procedural high-intensity statin administration in patients undergoing percutaneous coronary intervention..
Curr Med Res Opin. 31(2), 191-5.
(2015). Serum uric acid as an independent predictor of early death after acute stroke..
Circ J. 71(7), 1120-7.
(2007). Semaglutide, lipid-lowering drugs, and NAFLD..
Lancet Diabetes Endocrinol. 5(5), 329-330.
(2017). Seasonal variation in the occurrence of stroke in Northern Greece: a 10 year study in 8204 patients..
Neurol Res. 32(3), 326-31.
(2010). Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study..
Arch Med Sci. 7(5), 796-805.
(2011). Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis..
Lancet. 376(9756), 1916-22.
(2010). The role of statins in the treatment of type 2 diabetes mellitus: an update..
Curr Pharm Des. 20(22), 3665-74.
(2014). The role of statins for the primary and secondary prevention of coronary heart disease in women..
Curr Pharm Des. 15(10), 1054-62.
(2009). The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?.
Expert Opin Ther Targets. 11(2), 191-205.
(2007). The role of endocannabinoid system blockade in the treatment of the metabolic syndrome..
J Clin Pharmacol. 47(5), 642-52.
(2007). The role of ankle brachial index and carotid intima-media thickness in vascular risk stratification..
Curr Opin Cardiol. 25(4), 394-8.
(2010). Response to 'Mildly decreased glomerular filtration rate is associated with poor coronary heart disease outcome'..
Clin Cardiol. 35(5), 315; author reply 316-7.
(2012). Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome..
World J Gastroenterol. 21(25), 7860-8.
(2015). Relation of improvement in glomerular filtration rate with atorvastatin to reductions in heart failure morbidity..
Am J Cardiol. 110(5), 763.
(2012). Rectus sheath hematoma: a simplified emergency surgical approach..
Open Cardiovasc Med J. 5, 4-5.
(2011). Reaching hypertriglyceridemia goals..
Curr Med Res Opin. 30(3), 391-3.
(2014). Primary and secondary coronary heart disease prevention using statins: is targeting Adam or Eve equally effective?.
Expert Opin Pharmacother. 9(9), 1437-40.
(2008). Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?.
Curr Pharm Des. 16(34), 3939-847.
(2010). Preventing macrovascular complications of diabetes: where do we stand with glycemic control?.
Expert Opin Investig Drugs. 17(12), 1777-9.
(2008). Pleiotropic effects of statins--clinical evidence..
Curr Pharm Des. 15(5), 479-89.
(2009). Pheochromocytoma: an update on genetics and management..
Endocr Relat Cancer. 14(4), 935-56.
(2007).